Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Mohit Chawla, MD, FCCP, Robert P. Lee, MD, Nicholas Vander Els, MD, FCCP

Advertisement

Articles by Mohit Chawla, MD, FCCP, Robert P. Lee, MD, Nicholas Vander Els, MD, FCCP

MSK Pioneers Interventional Pulmonology Techniques in Lung Cancer Field

ByMohit Chawla, MD, FCCP, Robert P. Lee, MD, Nicholas Vander Els, MD, FCCP
February 15th 2018

Advanced interventional pulmonology techniques are revolutionizing the diagnosis and treatment of lung cancer.

Advertisement

Latest Updated Articles

  • MSK Pioneers Interventional Pulmonology Techniques in Lung Cancer Field
    MSK Pioneers Interventional Pulmonology Techniques in Lung Cancer Field

    February 15th 2018



Advertisement
Advertisement

Trending on OncLive

1

Tam-Peli Reduces Risk of Death by 54% vs Topotecan in Relapsed SCLC

2

Ris-Rez Extends Median OS to 18.5 Months vs Topotecan in Relapsed SCLC

3

Early Discontinuation of Adjuvant Osimertinib Doubles Recurrence Risk in EGFR-Mutated NSCLC

4

Dr Spira on the Data Supporting the Phase 3 Development of Iza-Bren in EGFR-Mutant NSCLC

5

Intercalated Gefitinib Plus Chemotherapy Improves DFS in Resected EGFR-Mutant NSCLC

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us